Literature DB >> 23391713

Factors associated with late antiretroviral therapy initiation in Cameroon: a representative multilevel analysis.

Jacques D A Ndawinz1, Basile Chaix, Sinata Koulla-Shiro, Eric Delaporte, Barnabe Okouda, Ambroise Abanda, Severin Tchomthe, Etienne Mboui, Dominique Costagliola, Virginie Supervie.   

Abstract

OBJECTIVES: Many people living with HIV/AIDS in resource-limited settings begin antiretroviral therapy (ART) at low CD4 counts. Here, we investigated the simultaneous effect of individual-, facility- and regional-level factors on late ART initiation.
METHODS: We conducted a survey in a nationally representative sample of 55 HIV treatment facilities in Cameroon. Medical records of 4935 patients >15 years of age who initiated ART in the month of October during the period 2007-10 were reviewed to gather individual characteristics. Late ART initiation was defined as CD4 count ≤ 100 cells/mm(3). Facility- and regional-level characteristics were also collected. Two-level regression logistic models were used to identify factors associated with late ART initiation.
RESULTS: Late ART initiation was associated with being a male younger than 45 years versus female younger than 45 years [adjusted OR (AOR) = 1.5, 95% CI: 1.3-1.7] and initiating ART in the period 2007-09 versus 2010 (AOR = 1.2, 95% CI: 1.0-1.4). Late initiation was more likely in central than in district hospitals (AOR = 1.3, 95% CI: 1.1-1.6) and in hospitals without a mother-to-child transmission programme (AOR = 1.9, 95% CI: 1.3-2.8). Living in a region with a higher comprehensive knowledge of HIV/AIDS was associated with not initiating ART late (AOR = 0.8, 95% CI: 0.6-1.0).
CONCLUSIONS: This study shows that risk factors associated with late ART initiation operate at multiple levels and that multilevel interventions are therefore necessary to promote earlier HIV testing and treatment.

Entities:  

Keywords:  HIV treatment; multivariate analysis; people living with HIV/AIDS; risk factors; sub-Saharan Africa

Mesh:

Substances:

Year:  2013        PMID: 23391713     DOI: 10.1093/jac/dkt011

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  14 in total

1.  Attrition from Care Among Men Initiating ART in Male-Only Clinics Compared with Men in General Primary Healthcare Clinics in Khayelitsha, South Africa: A Matched Propensity Score Analysis.

Authors:  Tali Cassidy; Morna Cornell; Bubele Makeleni; C Robert Horsburgh; Laura Trivino Duran; Virginia de Azevedo; Andrew Boulle; Matthew P Fox
Journal:  AIDS Behav       Date:  2022-07-31

2.  Implementation and operational research: Integrated pre-antiretroviral therapy screening and treatment for tuberculosis and cryptococcal antigenemia.

Authors:  Lincoln Pac; Mara Murray Horwitz; Anne Marion Namutebi; Brandon J Auerbach; Aggrey Semeere; Teddy Namulema; Miriam Schwarz; Robert Bbosa; Allan Muruta; David B Meya; Yukari C Manabe
Journal:  J Acquir Immune Defic Syndr       Date:  2015-04-15       Impact factor: 3.731

3.  Advanced HIV disease at entry into HIV care and initiation of antiretroviral therapy during 2006-2011: findings from four sub-saharan African countries.

Authors:  Maria Lahuerta; Yingfeng Wu; Susie Hoffman; Batya Elul; Sarah Gorrell Kulkarni; Robert H Remien; Harriet Nuwagaba-Biribonwoha; Wafaa El-Sadr; Denis Nash
Journal:  Clin Infect Dis       Date:  2013-11-05       Impact factor: 9.079

4.  Home visits during pregnancy enhance male partner HIV counselling and testing in Kenya: a randomized clinical trial.

Authors:  Alfred Onyango Osoti; Grace John-Stewart; James Kiarie; Barbra Richardson; John Kinuthia; Daisy Krakowiak; Carey Farquhar
Journal:  AIDS       Date:  2014-01-02       Impact factor: 4.177

5.  New indicators for delay in initiation of antiretroviral treatment: estimates for Cameroon.

Authors:  Jacques D A Ndawinz; Xavier Anglaret; Eric Delaporte; Sinata Koulla-Shiro; Delphine Gabillard; Albert Minga; Dominique Costagliola; Virginie Supervie
Journal:  Bull World Health Organ       Date:  2015-06-01       Impact factor: 9.408

6.  Exploratory Analysis of Time from HIV Diagnosis to ART Start, Factors and effect on survival: A longitudinal follow up study at seven teaching hospitals in Ethiopia.

Authors:  Alula M Teklu; Kesetebirhan Delele; Mulu Abraha; Bekele Belayhun; Esayas Kebede Gudina; Abiy Nega
Journal:  Ethiop J Health Sci       Date:  2017-02

7.  Gender-related differences in outcomes and attrition on antiretroviral treatment among an HIV-infected patient cohort in Zimbabwe: 2007-2010.

Authors:  Kudakwashe C Takarinda; Anthony D Harries; Ray W Shiraishi; Tsitsi Mutasa-Apollo; Abu Abdul-Quader; Owen Mugurungi
Journal:  Int J Infect Dis       Date:  2014-11-15       Impact factor: 3.623

8.  Factors associated with late presentation for HIV/AIDS care in Harare City, Zimbabwe, 2015.

Authors:  Howard Nyika; Owen Mugurungi; Gerald Shambira; Notion Tafara Gombe; Donewell Bangure; More Mungati; Mufuta Tshimanga
Journal:  BMC Public Health       Date:  2016-05-03       Impact factor: 3.295

9.  The clock is ticking: the rate and timeliness of antiretroviral therapy initiation from the time of treatment eligibility in Kenya.

Authors:  Thomas A Odeny; Brendan DeCenso; Emily Dansereau; Anne Gasasira; Caroline Kisia; Pamela Njuguna; Annie Haakenstad; Emmanuela Gakidou; Herbert C Duber
Journal:  J Int AIDS Soc       Date:  2015-10-26       Impact factor: 5.396

10.  A longitudinal review of national HIV policy and progress made in health facility implementation in Eastern Zimbabwe.

Authors:  Malebogo Tlhajoane; Tidings Masoka; Edith Mpandaguta; Rebecca Rhead; Kathryn Church; Alison Wringe; Noah Kadzura; Nimalan Arinaminpathy; Constance Nyamukapa; Nadine Schur; Owen Mugurungi; Morten Skovdal; Jeffrey W Eaton; Simon Gregson
Journal:  Health Res Policy Syst       Date:  2018-09-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.